Stock DNA
Pharmaceuticals & Biotechnology
VND Million (Micro Cap)
0
NA
0.00%
0.38
8.12%
0.00
Revenue and Profits:
Net Sales:
50,026 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,225 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.1%
0%
-4.1%
6 Months
5.41%
0%
5.41%
1 Year
3.54%
0%
3.54%
2 Years
-17.02%
0%
-17.02%
3 Years
112.73%
0%
112.73%
4 Years
-68.46%
0%
-68.46%
5 Years
-6.4%
0%
-6.4%
Lamdong Pharmaceutical JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.40%
EBIT Growth (5y)
22.02%
EBIT to Interest (avg)
-2.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
1.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.91%
ROE (avg)
6.47%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
3.33
EV to EBITDA
2.20
EV to Capital Employed
0.27
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
8.20%
ROE (Latest)
6.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
50,026.30
60,900.60
-17.86%
Operating Profit (PBDIT) excl Other Income
2,327.40
4,131.50
-43.67%
Interest
555.60
2,038.10
-72.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,225.00
1,014.40
20.76%
Operating Profit Margin (Excl OI)
18.60%
43.30%
-2.47%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -17.86% vs -15.16% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 20.76% vs -66.42% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
217,957.80
186,000.70
17.18%
Operating Profit (PBDIT) excl Other Income
20,135.00
-4,218.70
577.28%
Interest
4,978.60
7,026.60
-29.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6,919.00
-20,104.90
134.41%
Operating Profit Margin (Excl OI)
60.90%
-66.40%
12.73%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 17.18% vs -0.75% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 134.41% vs 48.33% in Dec 2023
About Lamdong Pharmaceutical JSC 
Lamdong Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Lamdong Pharmaceutical Joint Stock Company (Ladophar) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacturing and wholesale trading of pharmaceutical products, as well as functional food, alcoholic and non-alcoholic beverages, including tea and soft drinks. It also imports and exports materials for drug manufacturing activities, along with other medical equipment and supplies. In addition, the Company operates a hotel in Da Lat City, Lam Dong Province. The Company's revenue is derived from four segments: Dalat office and other provinces, drug store system in Lam Dong Province, Hochiminh City branch and Hanoi branch.
Company Coordinates 
Company Details
So 18 Ngo Quyen, Phuong 6 , DA LAT None : None
Registrar Details






